establishment characterization 5fu resistant oscc line 5fu resistant oscc line establish prolong treatment 5fu oscc cell line describe supplementary material method monitor cell viability 5fu sensitive 5fus resistant 5fur pattern h357 scc4 scc9 cell line mtt assay suggest 5fur cell achieve acquire resistance fig s1a b. reduce expression γh2ax 5fu treat resistant cell contrast 5fu treat sensitive cell also confirm acquire resistance 5fu 5fur cell fig s1c enhance cancer like stem cell cscs elevate expression atpbinding cassette abc transporter hallmark chemoresistant cell qrtpcr data suggest csc marker sox2 oct4 nanog well majority abc transporter expression elevate 5fur cell compare 5fus cell fig s1d e. flow cytometry data suggest percentage thymidylate synthase positive cell hall mark 5fu resistance significantly higher 5fu resistant cell compare 5fu sensitive oscc line fig s1f g. similarly expression thymidylate synthase elevate 5fu resistant cell compare sensitive cell fig s1h understand role potential kinase signal 5fu resistance oscc crispr base kinomewide screen perform use lentiviral sgrna library knock 840 kinase individually total number 3214 sgrna construct target individual kinase 4 sgrna lentiviral construct pool together kinome screen cas9 stable overexpressing 5fu resistant oscc line establish fig s2 show similar drug resistant pattern parental 5fur oscc line fig s3a also determine polybrene puromycin tolerance concentration cas9 overexpressing clone fig s3b c. 5fus 5fur line treat 5fu cell death measure high content analyzer use fluorescent cell viability dye data suggest significantly lower cell death 5fur cell compare 5fus cell harmony previously measure 5fu tolerance line fig s4ac screen protocol optimize use appropriate positive negative control 6tg 6thioguanine treat hprt1 hypoxanthine phosphoribosyltransferase 1 ko line use positive control screen show resistance cell death whereas hprt1 wt cell sensitive 6tg suggest optimize screen protocol fig s4d e. negative control lentivirus express scramble sgrna use primary screen 5fu resistant line h357 5fur transduce lentivirus base library contain sgrnas target 840 individual kinase sub lethal dose 5fu treat 48 h follow measure cell death high content analyzer use fluorescent cell viability dye fig 1a primary screen 334 kinase 840 select consideration reject rest sgrna clone alone induce cell death 30 fig 1b c table s1 60 candidate kinase lowest survival fraction score evaluate secondary screen use three chemoresistant line i.e scc4 5fur scc9 5fur h357 cisr along h357 5fur primary secondary screen mink1 sbk1 fkbp1a emerge three common kinase among 5fur line mink1 lowest survival fraction score sensitize chemoresistant cell 5fu fig 1cf table s2 secondary screen mink1 knock show minimal efficacy sensitize cisplatin resistant cell line cisplatin fig 1e table s2 indicate specific role mink1 towards acquire 5fu resistance next find expression mink1 significantly higher 5fur line compare 5fus line oscc fig 1g evaluation clinical sample expression mink1 find elevate tumor tissue chemotherapy nonresponders compare chemotherapy responder fig 1h table s3 also evaluate mink1 expression drugnaive postct nonresponder pair tumor sample patient observe postcttreated tumor sample show higher mink1 expression fig 1j k table s3 confirm find kinome screen mink1ko knock clone generate use lentivirus express two different sgrnas sgrna1 sgrna2 cas9 overexpressing 5fur oscc line patient derive line 2 pdc2 fig s5a pdc2 isolate characterize earlier tumor chemotherapynonresponder patient treat neoadjuvant tpf without response 10. colony form mtt spheroid assay data suggest knock mink1 significantly reduce cell viability chemoresistant cell treat 5fu fig s5b c fig 2a rest experiment sgrna1 use knock mink1 similarly knock mink1 induce 5fu mediate cell death chemoresistant cell fig 2b enhance ph2ax cleave parp observe mink1ko cell follow treatment 5fu indicate potential role mink1 mediate 5fu resistance fig 2c d. test vivo efficacy kinome screen data implant pdc2 mink1wt cell right upper flank pdc2 mink1ko cell leave upper flank nude mouse follow treatment 5fu treatment 5fu 10 mgkg significantly reduce tumor burden mink1ko mink1wt group fig 2eg immunohistochemistry data suggest markedly decrease cell proliferation signal ki67 5futreated mink1ko tumor fig 2h earlier prove selective knockdown mink1 decrease migration human breast cancer line 8. evaluate whether depletion mink1 also reduce migration chemoresistant oscc line pdc2 boyden chamber assay scratchwound heal assay perform data suggest knock mink1 follow treatment 5fu significantly reduce relative number migrate cell fig s6a similarly scratch area analysis suggest percentage scratch area significantly higher 5fu treat mink1ko drug resistant cell fig s6b c. qpcr immunoblotting data suggest expression level abc transporter thymidylate synthase significantly lower mink1ko drug resistant cell hand mink1 ectopically overexpressed sensitive oscc line find increase expression thymidylate synthase fig s7ac next use zebrafish danio rerio tgfli1 egfp tumor xenograft model validate find equal number pdc2wt pdc2mink1 ko cell stain dil 1,1'dioctadecyl3,3,3',3'tetramethylindocarbocyanine perchlorate inject perivitelline space 48h post fertilize zebrafish embryo 3 day injection embryo treat vehicle control 5fu 500 08m 5 day injection primary tumor metastatic distribution cancer cell document use fluorescence microscope tumor growth measure fluorescence intensity primary tumor find significantly reduce mink1 ko group treatment 5fu fig 2i j. also cancer cell show reduce distal migration primary site case mink1 ko 5fu treat group fig 2k data indicate mink1 dependency 5fu resistant oscc explore potential role mink1 5fu sensitive cell knock mink1 5fu sensitive cell measure cell viability mtt assay suggest knock mink1 result higher sensitivity 5fu compare mink1 wt cell fig s8a b. confirm potential role mink1 5fu resistance perform gain function study use lentiviral approach generate mink1shrna stable clone 5fur line pdc2 mink1utrkd shrna target 3'utr mink1 mrna ectopic overexpression mink1 mink1utrkd cell transfected plenti cmvto puro dest mink1 vector fig 3a cell viability cell death data suggest knock mink1 5fur cell result sensitize resistant cell 5fu however ectopic overexpression mink1 rescue 5fu resistant phenotype fig 3b c. similarly immunostaining data suggest enhance ph2ax signal mink1utrkd cell whereas ectopic overexpression mink1 reduce ph2ax signal indicate rescue 5fu resistance oscc cell fig 3d also observe rescue cleave parp ectopic expression mink1 suggest reduce cell death fig 3e mink1 stably overexpressed oscc sensitive line cell show resistance 5fu induce cell death fig 3f g. hand kinase dead form mink1 k54r stably overexpressed oscc sensitive line cell show resistance 5fu induce cell death data suggest mink1 kinase activity require 5fu resistance oscc fig 3g kinase dead mink1 generate mutate lysine k 54 arginine r. understand specific role mink1 5fu resistant oscc perform highthroughput phosphorylation profile 1318 sitespecific antibody 30 signal pathway 5fur cell stably express mink1ko mink1wt study phosphorylation p53 ser33 ser15 find significantly regulate mink1ko cell compare mink1wt cell addition phosphorylation akt ser473 phosphorylation mdm2 ser166 find regulate mink1ko cell compare mink1wt fig 4a immunoblotting perform validate find phosphoantibody array data suggest phosphorylation p53 ser15 ser33 significantly upregulated phosphorylation mdm2 ser166 profoundly downregulated mink1ko cell compare mink1wt chemoresistant cell fig 4b p53 expression also find inversely correlate mink1 irrespective mutation status fig 4b s9a though p53 scc4 h357 missense mutation codon 151 scc4 codon 110 h357 p53 expression detectable mrna protein level case scc9 p53 deletion mutation codon 274285 detectable expression 11 12. mcf7 hek 293 hct116 wild type p53 expression 13. selective knock mink1 scc45fur h3575fur cell result significantly higher degree sensitivity 5fu compare scc9 5fur fig 2a s9b similarly selective knock mink1 hct116 cell show higher sensitivity 5fu compare ntshrna cell fig s9c next mink1 ectopically overexpressed mink1kd shrna target 3'utr clone downregulation p53 pp53 ser33 pp53 ser15 observe chemoresistant oscc line fig 4c explore mink1 kinase activity require regulation p53 stably overexpressed wt mink1 kinase dead mink1 k54r oscc sensitive cell immunoblotting data suggest little regulation p53 pp53 ser15 cell stably express kinase dead domain form mink1 fig s10 harmony find phosphorylation array paktser473 find regulate mink1 deplete cell rescue ectopic overexpression mink1 fig 4d e. confirm potential role akt modulate mink1 mediate p53 regulation ectopically overexpressed constitutively active akt myrakt mink1ko cell immunoblotting data suggest expression p53 pp53 ser33 pp53 ser15 downregulated myrakt overexpressed mink1ko cell fig 4f similarly mink1 express cell treat akt inhibitor akti12 p53 expression rescue along downregulation pmdm2 ser166 fig 4g p53 target gene also evaluate immunoblotting data suggest expression p21 noxa tigar mink1ko clone upregulated compare mink1wt clone fig 4h screen data observe mink1 expression elevate chemoresistant oscc genetic inhibition sensitize drug resistant line 5fu induce cell death hence mink1 potential therapeutic target overcome chemoresistance oscc limit information inhibitor mink1 available literature hence look potential mink1 inhibitor international union basic clinical pharmacology iuphar database screen 72 inhibitor 456 human kinase bind activity provide among potential twelve mink1 inhibitor test mink1 inhibitory activity three inhibitor i.e. staurosporine pexmetinib lestaurtinib kinase assay data suggest lestaurtinib pexametinib highest inhibitory activity mink1 fig 5a 50 mink1 inhibitory activity observe concertation 100 nm case lestaurtinib 10 08m pexmetinib fig 5b next cell viability assay perform select dose lestaurtinib pexmetinib affect cell viability treat alone viability 80 5fu resistant oscc line fig 5c d. cell viability spheroid assay cell death data suggest select sub lethal dose lestaurtinib 50 nm pexmetinib 500 nm efficiently restore 5fu mediate cell death chemoresistant oscc line pdc2 fig 5e f s11a ic50 value 5fu h3575fur 20.49 μm however combination lestaurtinib 50 nm decrease ic50 value 4.82 μm combination pexmetinib 500 nm lower ic50 value 5fu 7.08 08m fig 5e lestaurtinib much lower concentration 50 nm compare pexmetinib 500 nm sensitize 5fu chemoresistant cell lestaurtinib consider rest study enhance expression ph2ax cleave parp observe combination group lestaurtinib 5fu indicate program cell death fig 5g s11b boyden chamber assay data suggest combinatorial treatment lestaurtinib 5fu significantly reduce relative number migrate cell fig s11c harmony observation make knockout mink1 chemoresistant cell also find lestaurtinib significantly decrease phosphorylation mdm2ser166 aktser473 elevate expression p53 chemoresistant cell fig 5h find lestaurtinib fail sensitize 5fu mediate cell death mink1 knock 5fur line fig 5i suggest lestaurtinib confer 5fu sensitivity inhibit mink1 kinase activity check vivo efficacy novel combination nude mouse xenograft model perform use patient derive cell pdc2 vivo data suggest combination lestaurtinib 20 mgkg 5fu 10 mgkg profoundly reduce tumor burden compare treatment either single agent fig 6ac immunohistochemistry data suggest significant reduction cd44 ki67 expression along increase expression cleave caspase 3 combination group fig 6d finally perform combinatorial antitumor effect noncytotoxic extremely low dose cisplatin 1 μm 5fu 1 μm lestaurtinib 50 nm pdc2 cell viability cell death western blot colony form assay data suggest significantly higher cell death cisplatin 5fu lestaurtinib combinatorial group compare possible combinatorial group i.e 5fu lestaurtinib cisplatin lestaurtinib cisplatin 5fu fig